Advanced

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial.

Olsson, Bertil LU (2003) In The Lancet 362(9397). p.8-1691
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
The Lancet
volume
362
issue
9397
pages
8 - 1691
publisher
Elsevier Limited
external identifiers
  • scopus:0345414673
ISSN
1474-547X
DOI
10.1016/S0140-6736(03)14841-6
language
English
LU publication?
yes
id
5642efce-287b-470e-8f2d-58d46a12261f (old id 119874)
alternative location
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14643116&dopt=Abstract
date added to LUP
2007-07-02 11:54:46
date last changed
2018-02-18 03:36:04
@article{5642efce-287b-470e-8f2d-58d46a12261f,
  author       = {Olsson, Bertil},
  issn         = {1474-547X},
  language     = {eng},
  number       = {9397},
  pages        = {8--1691},
  publisher    = {Elsevier Limited},
  series       = {The Lancet},
  title        = {Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial.},
  url          = {http://dx.doi.org/10.1016/S0140-6736(03)14841-6},
  volume       = {362},
  year         = {2003},
}